These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10720075)

  • 21. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction.
    Zlotta AR; Djavan B; Marberger M; Schulman CC
    J Urol; 1997 Apr; 157(4):1315-21. PubMed ID: 9120930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue.
    Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Marks LS; Song W; Wheeler TM; Slawin KM
    Cancer Res; 2000 Feb; 60(3):756-9. PubMed ID: 10676664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate specific antigen adjusted for transition zone epithelial volume: the powerful predictor for the detection of prostate cancer on repeat biopsy.
    Ohigashi T; Kanao K; Kikuchi E; Nakagawa K; Nakashima J; Marumo K; Murai M
    J Urol; 2005 May; 173(5):1541-5. PubMed ID: 15821482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen.
    Stenman UH; Leinonen J; Zhang WM; Finne P
    Semin Cancer Biol; 1999 Apr; 9(2):83-93. PubMed ID: 10202130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The relationship of PSA to age and prostatic volume in patients with benign prostatic hypertrophy].
    Sánchez Sánchez E; Paez Borda A; Herrero Payo A; Ruiz Rubio JL; Acebal Lucía J; Berenguer Sánchez A
    Actas Urol Esp; 1995 Mar; 19(3):181-6. PubMed ID: 8659273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
    O'Neil LM; Walsh S; Cohen RJ; Lee S
    BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 patients.
    Gjengstø P; Halvorsen OJ; Akslen LA; Frugård J; Hoisaeter PA
    Urology; 2003 Sep; 62(3):447-50. PubMed ID: 12946744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.
    Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA
    Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?
    Prestigiacomo AF; Stamey TA
    J Urol; 1997 Jan; 157(1):189-94. PubMed ID: 8976248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical practice of the transrectal shear-wave elastography in benign prostatic hyperplasia.
    Zhang X; Chen Z; You J; Lu Q; Liu L; Cai D
    Aging Male; 2024 Dec; 27(1):2363267. PubMed ID: 38867423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men.
    Kehinde EO; Mojiminiyi OA; Sheikh M; Al-Awadi KA; Daar AS; Al-Hunayan A; Anim JT; Al-Sumait AA
    BJU Int; 2005 Aug; 96(3):308-12. PubMed ID: 16042719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume.
    Stamey TA; Yemoto CE
    J Urol; 2000 Jan; 163(1):119-26. PubMed ID: 10604328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer.
    Ornstein DK; Smith DS; Humphrey PA; Catalona WJ
    J Urol; 1998 Apr; 159(4):1234-7. PubMed ID: 9507843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Hinerman-Mulroy A; Galbreath RW
    Brachytherapy; 2003; 2(3):181-8. PubMed ID: 15062141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI phenotype of the prostate: Transition zone radiomics analysis improves explanation of prostate-specific antigen (PSA) serum level compared to volume measurement alone.
    Krauss T; Engel H; Jilg CA; Gratzke C; Bamberg F; Benndorf M
    Eur J Radiol; 2020 Aug; 129():109063. PubMed ID: 32516697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zonal anatomy of the prostate using magnetic resonance imaging, morphometrics, and radiomic features: impact of age-related changes.
    Laschkar S; Montagne S; De Kerviler E; Roupret M; Lucidarme O; Cussenot O; Renard Penna R
    Br J Radiol; 2022 Mar; 95(1131):20210156. PubMed ID: 34541863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systematic ultrasound guided transrectal core prostate biopsy based on serum level of prostate-specific antigen].
    Yamaguchi S; Baba Y; Naito K
    Hinyokika Kiyo; 1997 Sep; 43(9):641-5. PubMed ID: 9365843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
    Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
    Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.